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Summary 
The T  lymphocytes mediating autoimmune destruction of pancreatic [3 cells in the nonobese 
diabetic  (NOD)  mouse model of insulin-dependent  diabetes mellitus (IDDM) may be gener- 
ated  due  to  functional  defects  in  hematopoietically derived  antigen-presenting  cells  (APC). 
However, it has not been clear which particular subpopulations ofAPC (B lymphocytes, mac- 
rophages, and dendritic cells) contribute to the development and activation of diabetogenic T  cells 
in  NOD  mice.  In the  current  study we  utilized  a  functionally inactivated immunoglobulin 
(Ig)l.*  allele  (Ig/x  ''a) to  generate  a  "speed congenic"  stock  of B  lymphocyte-deficient NOD 
mice that are fixed for linkage markers delineating previously identified diabetes suscepnbility 
(Ida") genes, These B lymphocyte NOD.Igi.,, ''tt mice had normal numbers of T  cells but were 
free of overt IDDM and insulitis resistant, while the frequency of disease  in the B lymphocyte 
intact segregants was equivalent to that of standard NOD  mice in our colony. Thus, B  lym- 
phocytes play a heretofore unrecogmzed role that is essential for the initial development and/or 
activation of [3 cell autoreactive T  cells in NOD mice. 
I 
nsulin-dependent  diabetes mellitus (IDDM)  in the non- 
obese diabetic  (NOD)  mouse model results from auto- 
immune destrucuon of pancreatic 13 cells mediated by both 
CD4 + and CD8 + T  lymphocytes (1, 2).  However, while 
T  lymphocytes are clearly the final mediators of 13 cell de- 
struction in NOD mice, there is evidence that these auto- 
reactive effectors are generated as a consequence  of func- 
tional defects in hematopoietically derived APC such as 
B  lymphocytes, macrophages, and dendritic  cells  (2).  Dia- 
betes  susceptibility  (Idd)  genes both inside  and  outside  of 
the unusual H2v v MHC haplotype appear to contribute to 
diabetogenic  APC  defects  in  NOD  mice.  However,  the 
mechanisms whereby APC contribute to the development 
ofautoimmune IDDM in NOD mice are unknown. Possi- 
bilities include  a  unique  ability of NOD  APC  to  process 
and immunologically present certain [3 cell proteins, and/or 
a reduced capacity to activate tolerogenic mechanisms that 
normally anergize  or  delete  diabetogemc  T  lymphocytes. 
Another, not mutally exclusive, possibility  is that NOD APC 
preferentially induce  [3 cell autoreactive CD4 ÷ T  lympho- 
cytes  to  secrete  cytokines  characteristic  of  a  potentially 
pathogenic  Thl  response,  rather  than  those  of a  Th2  re- 
sponse that may dampen pathogenesis.  However, it is not 
known if any of these potentially diabetogenic dysfunctions 
in  NOD  mice are  exerted by all  or particular subpopula- 
tions of APC. 
It  has  been  proposed  that  B  lymphocytes  may  play  a 
more critical role in the induction of immunological toler- 
ance than  other APC  populations.  This possibility is sup- 
ported by reports that B lymphocytes have a greater capac- 
ity than other types of APC to induce T  cell anergy and to 
preferentially  activate  Th2  rather  than  Thl  cytokine  re- 
sponses (3, 4). However, this conclusion was questioned by 
a recent report (5) demonstrating that peripheral T  cell tol- 
erance  could be  induced  normally in  mice  made  B  lym- 
phocyte  deficient  by  congenic  transfer  of the  previously 
described Iglx allele (6) that has been functionally disrupted 
by homologous recombination (originally abbreviated IxMT  °, 
now  formally  designated  Igh6 'mtcg',  and  here  designated 
Igtx  "utl for clarity). Specific subpopulations of APC may also 
differentially contribute  to  IDDM susceptibility m  NOD 
mice if they present varying mosaics of 13 cell autoantigens 
to T  lymphocytes. Indeed, some proteins can only be an- 
tigenically processed and presented to T  cells by B lympho- 
cytes (7).  This process may lead to the development of au- 
toimmunity if B  lymphocytes activate normally quiescent 
self-reactive T  cells that had escaped tolerogenic mechamsms 
because the antigenic  determinants they recognize are not 
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APC  (8).  To  understand  the  relative  roles  various  APC 
subpopulations  play  in  the  development  of autoimmune 
IDDM,  we examined if pathogenesis was altered in a  con- 
genic stock of B  lymphocyte-deficient NOD.Ig/z ""it mice. 
Table 1.  Linkage Markers Analyzed to Fix NOD-derived Idd 
Loci to Homozgosity in the NOD.Igtz  È"lt Congenic Stock 
Idd locus/chromosome 
Linkage marker  Relatave 
homozygous for  microsatelhte 
NOD allele  size 
Materials and Methods 
Development  of a  "Speed  Congenic"  Stock  of NOD.Igt  x""tt Mice. 
The Iglz ""It allele funcuonally disrupted by insertxon of a neomy- 
cin resistance  gene  (neo  ~) was backcrossed from the original chi- 
meric  stock with  a  mixed  129  and  C57BL/6  (B6)  genome  (6) 
onto the NOD/Lt inbred background. The heterozygous carriers 
of the Igl  ~""tt allele used as breeders at each backcross  generation 
were identified by typing DNA isolated from PBL by PCR with 
the primer set 5'-GCTATTCGGCTATGACTGGG-3'  and  5'- 
GAAGGCGATAGAAGGCGATG-3', which generates a 706-bp 
product from within the neo' insert. Each of 35 amplification cy- 
cles  on  a  PTC-100  thermal  cycler  (MJ  Research,  Watertown, 
MA) consisted of denaturation at 94°C for 30 s, primer annealing 
at 60°C for 30 s, and extension at 72°C for 30 s. Using previously 
described PCR methodologies (9,  10),  segregants from the fourth 
and  sixth  backcross  (N5  and  N7,  respectively)  generation  were 
genotyped for the microsateUite markers  shown in Table  1 that 
are linked to the indicated Idd lOCL At the N7 backcross genera- 
tion, Iglz  n~Iv+ heterozygotes shown by these PCR analyses to be 
fixed  as  homozygous  for  NOD  alleles at  the  indicated  linkage 
markers of Idd susceptibility loci were intercrossed. PBL from the 
resulting F1  progeny were  typed by two-color flow cytometric 
analysis  (FACScan  ®, Becton Dickinson and  Co.,  San Jose,  CA) 
for the  presence  or absence  of B  lymphocytes  using  an  FITC- 
conjugated  goat  polyclonal  antiserum  specific  for  mouse  IgM 
(Southern  Biotechnology Associates,  Birmingham,  AL)  and  the 
B220 specific mAb RA3-6B2 conjugated to PE. Segregants lack- 
ing B lymphocytes were scored as NOD.Ig/x  ""u homozygotes, and 
have been maintained by brother-sister mating. B lymphocyte in- 
tact  N7F1  progeny  were  scored  as  wild-type  Ig~  +/+  homozy- 
gotes  af the  neo  r insert  could  not  he  detected  by  PCR.  N7FI 
progeny carrying the neo' insert, but posiuve for B  lymphocytes, 
were scored as Iglx  ""iv+ heterozygotes. All mace were maintained 
under  specific pathogen-free  (SPF)  conditions and  allowed free 
access to food (Agway diet NIH 31A; PMI Feeds Co., South Hen- 
ley, MO) and acidified drinking water. 
Assessment of Diabetes, Insulitis,  and Leukocyte Subsets.  B  lym- 
phocyte  intact  and  deficient segregants  were  monitored weekly 
for  the  development  of glycosuna  wath  Ames  Diastix  ~  (kindly 
supplied by Miles Laboratories Inc., Elkhart, IN). Glycosunc val- 
ues of i>3 were considered diagnostac  of diabetes onset.  Pancre- 
ases from mace that remained normoglycemac through 20 wk of 
age were fixed an Boum's solution, secuoned at three nonover- 
lapping levels, and stained wath aldehyde fuchsln for histological 
analysis  of insulius  development.  Islets (at  least 25/mouse)  were 
individually scored as follows: 0, no lesions;  1, perimsular leuko- 
cytlc aggregates,  usually penductal  infiltrates;  2,  <25%  islet de- 
struction; 3, >25% islet destruction; 4, complete islet destruction. 
An insulins  score for each mouse was  obtained by dividing the 
total score for each pancreas  by the  number  of islets  examined. 
Data are presented as mean insulitis  score -+ SEM for the indicated 
number  of B  lymphocyte  intact  or deficaent segregants.  Splemc 
leukocytes from mice that remained non diabetic through 20 wk 
of age were typed by FACS  ® for the presence of B  lymphocytes 
with a goat polyclonal antiserum specific for mouse Ig (Southern 
Idd1=H297/17  *D17Mit34=C4  B6=129>NOD 
Idd2/9  *D9Mit25  NOD >B6> 129 
Idd3/3  D3Mit206  NOD>  129>B6 
*D3Nds6= 112  B6 >NOD = 129 
D3Mit95  NOD >B6 = 129 
Idd 4 /11  D I 1Mit115  NOD>B6=  129 
*D11Nds16=Acrb  NOD=129>B6 
D11Mit320  129>NOD>B6 
Idd5/1  *D 1Mit5  NOD = 129 >B6 
D IMit 18  NOD >B6 = 129 
*D1Mit46  NOD=  129>B6 
Idd6/6  D6Mit52  B6 = 129>NOD 
D6Mit339  B6>NOD>  129 
Idd7/7  *D7Mit20  B6= 129>NOD 
Idd8,  Iddi2/14  *D14Mitl 1  B6>NOD 
D14Mit110  129>NOD>  B6 
D14Mit222  NOD>B6=  129 
Idd9,  Iddl 1/4  *D4Mit59  NOD>B6 = 129 
Idd10/3  D3Nds l I  B6= 129>NOD 
*D3Nds8= Tshb  NOD = 129>B6 
D3Mit 103  B6>NOD > 129 
Idd13/2  D 2Mit3 95  129>B6>NOD 
*B2m  NOD = 129~B6~ 
D2Mit 17  NOD > 129 >B6 
Idd14/13  *D13  Mit  61  NOD>B6=  129 
Idd15/5  *D5Mit48=Pgyl  B6>NOD 
D5Mit69  NOD>B6=  129 
Microsatellites  markers  with  the  indicated  allehc  size  variants  were 
typed in N5 backcross mice and in the N7 segregants used for the rater- 
CROSS. 
*Markers  typed  as  homozygous  for  allehc  variants  charactenstlc  of 
NOD in the single N5 female serving as the progenitor for all mice In 
subsequent  backcross generations. 
*[32m allelic variants were typed as previously described  (9) by BglI di- 
gestion of the PCR product. 
Biotechnology Associates),  and  for macrophages  (M~),  CD4 +, 
and  CD8 + T  lymphocytes with  the mAbs M1/70,  GK1.5,  and 
53-6.72, respectively. 
Results 
Genetic  Characterization  of the NOD.Igl  ~n"tt "Speed Congenic" 
Stock.  Heterozygous  carriers  of the Igtx  "utt allele from the 
N5  backcross  generation were  genotyped by PCIL for the 
markers  denoted by an asterisk in Table  1 that  were previ- 
ously shown  to  be closely linked to  the indicated  Idd loci. 
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Figure 1.  Diabetes  development  through 20 wk of age in NOD.lgp, ""11, 
NOD.Ig/x  ""~v÷, and  NOD.Ig/x  +/+  segregants at  the  BC6  generation. 
Symbols: NOD.Igt  x"'tl females (n  =  8,  A)  and  males (n  =  9,  &); 
NOD.Igtx ""l~/+ females (n =  10, C)) and males (n =  11, 0); NOD.Iglx +/~ 
females (n =  10, [3) and males (n = 6, all). Chi-squared analysis  demon- 
strated that while significantly  higher (P <0.01) than m B lymphocyte- 
deficient NOD.Igp,  ~"tI male and females, the  cumulauve incidence of 
IDDM at 20 wk of age did not &ffer statistically  (P >0.9) between sex- 
matched B lymphocyte-intact  Igt.t  °~tv+ or lgtx  +/÷ segregants. 
This  analysis identified a  single N5  female  that  was  ho- 
mozygous for allelic variants characteristic of NOD mice at 
all of these Idd linkage markers.  This female served as the 
progenitor for all mice in subsequent backcross generations. 
We also genotyped the NOD,  129, and B6 parental strains 
for  a  series  of additional microsatellites marking chromo- 
somal regions carrying Iddi-15.  This enabled us to identify 
the series of linkage markers shown in Table 1 that delin- 
eate NOD  genomic elements from those derived from ei- 
ther the  129  or B6  strains. Typing of these markers con- 
firmed the homozygous presence of NOD derived genome 
at  all previously identified Idd  loci in the  N7  progenitors 
used for the intercross (Table 1). 
NOD.Iglx ""u  Mice  Are  IDDM  and  Insulitis-resistant. 
Currently, IDDM develops in 90%  of standard NOD/Lt 
female and 63% of male mice at The Jackson Laboratory by 
1  year of age.  This susceptibility has  been fully reconsti- 
tuted in the speed congenic stock of NOD.Igl  x~uu mice as 
evidenced by the  IDDM incidence in the  B  lymphocyte 
positive segregants from the  N7  backcross generation. By 
20 wk of age,  IDDM developed in 70%  (7/10)  of female 
and  50%  (3/6)  of male  N7F1  NOD.Igtx +/+  segregants. 
Similarly, IDDM also  developed in 90%  (9/10)  of female 
and 45.5% (5/11) of male N7F1 NOD.Igl  xnutl/+ segregants. 
Mean insulitis scores of the B lymphocyte intact segregants 
that  remained free  of overt  IDDM  through  20  wk were 
3.89  -+ 0.10 (n =  4) in females and 3.28 +  0.32 (n =  9) in 
males. The extensive insulitis and high frequency of IDDM 
in  these  two  groups  of B  lymphocyte intact  N7F1  seg- 
regants is equivalent to that observed in our standard NOD 
mice at the same age. This provided a functional confirma- 
tion of the linkage marker analyses (Table 1) demonstrating 
that the NOD-derived Idd loci necessary for disease devel- 
opment had been fixed in the  N7  segregants.  In marked 
contrast,  IDDM  failed to  develop  in any B  lymphocyte- 
deficient female (0/8) or male (0/9) N7 NOD.Iglx "utt mice 
(Fig.  1).  These NOD.Igtx ""tl mice were also virtually free 
of insulitls as evidenced by mean insulitis scores at 20 wk of 
age  of 0.31  +  0.06  (n  =  5)  in females and 0.23  --  0.02 
(n =  5)  in males. These scores reflected, at most, the pres- 
ence  of perivascular/penductal leukocytic aggregates,  but 
no intraislet infiltrates. This virtual absence of insulitis in 
NOD.Igl  x""lt mice indicates that IDDM development is not 
merely  delayed,  but  that  [3  cell-autoreactive  T  cell  re- 
sponses are  not initiated in this stock.  The  Igtx  structural 
gene is located on distal chromosome 12 in a region where 
genome-wide scans have failed to detect any Idd loci. Col- 
lectively, these  results indicate that elimination of B  lym- 
Table 2.  Splenic  Leukocyte Profiles of NOD.Igtx ""~l, NOD.Igmtx""Ul, and NOD.Igl  x+/+ Segregants 
No. B  No. CD4  No. CD8 
Percent B  cells  Percent CD4  T cells  Percent CD8  T cells  No. MQ 
Genotype  cells  (×  106)  T cells  (×  106)  T cells  (×  106)  Percent MO  (×  106) 
Iglx  ""tt  0.12  0.05  58.1  22.6  21.8  8.0  8.6  2.9 
(n =  3)  +  0.05  +  0.03  _+ 3.6  +  8.2  m 0.7  +  2.6  +  1.4  --+ 0.8 
Iglx""ll/+  35.8  34.3  32.4  30.7  8.5  8.1  5.9  5.5 
(n =  4)  +_ 1.2  +_ 3.0  +_ 1.1  +  2.4  +  1.2  ±  1.4  +-- 0.6  +  0.5 
Igtx  +/+  39.9  40.6  28.8  29.4  9.1  9.3  5.7  5.6 
(n =  6)  --+ 1.2  +  4.1  +_  1.0  _+ 3.1  --+ 0.7  +  1.1  +  0.5  --+ 0.4 
Splemc leukocytes from BC6 segregants remaining nondiabetic through 20 wk of age were typed by FACS  ®  as described in Matenals and Methods 
for the presence ofB lymphocytes, CD4 and CD8 T lymphocytes, and MO. Data represent percentage or absolute number +  SEM of each leuko- 
cyte population. 
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ficient  to  block  IDDM  development  in  an  otherwise 
genetically susceptible NOD mouse stock. 
Normal  T  Cell Lymphocyte  Development  in B  Lymphocyte-- 
deficient NOD.Igl.t "uH Alice.  It was important to determine 
if the absence of IDDM and insulitls in NOD.Ig/z"'" mice 
resulted solely from the  elimination  of B  lymphocytes, or 
whether this mutation also rendered mice T  lymphopenic. 
Thus, we used FACS ® analysis  to compare the percentages 
and absolute numbers ofB lymphocytes, CD4 + and CD8 + 
T  lymphocytes,  and  MO  in  the  spleens  of 20-wk-old 
NOD.Igtz "uu, NOD.Igt  z'ulv +, and NOD.Igl.t +/+ segregants. 
As shown in Table 2, B lymphocytes were present and did 
not differ in proportion or absolute number in spleens  of 
Igl.t  n"u/+ and Iglz  +/+ segregants.  As expected, B lymphocytes 
were absent in spleens of Igtz  "~H segregants. The proportion 
of CD4 +  and  CD8 +  T  lymphocytes in  spleens  of Iglz  "~tt 
segregants was two to  three  times higher than  in Igt  x'~tv+ 
and  Igl.t +/+  segregants.  However,  this  was  due  solely to 
the absence ofB lymphocytes in mice homozygous for the 
Igt  zÈ~" allele,  since  the  absolute numbers of splenic  CD4 + 
and CD8 + T  lymphocytes were similar in all three segrega- 
tion classes. Silmlarly, the proportion, but not the absolute 
number of MO was also increased in spleens of Igtx ~"II seg- 
regants compared with either class of B lymphocyte-intact 
segregants. When compared at 6 wk of age, total numbers 
of splenic  T  cells  and  M~  also  did  not  differ  between 
NOD.Ig/z  ""u and  standard  NOD  mice.  Thus,  the  genetic 
elimination of B lymphocytes does not appear to quantita- 
tively effect the  development of other leukocyte popula- 
tions in NOD mice. 
Discussion 
It has been previously demonstrated that T  lymphocytes 
from diabetic NOD  donors  can efficiently transfer disease 
to neonatal recipients depleted of B lymphocytes by treat- 
ment with a It-specific mAb (11).  Thus, after diabetogenic 
T  lymphocytes have been generated they can clearly me&ate 
destruction  of pancreatic  [3  cells in the absence of B  lym- 
phocytes.  However,  our  current  study  demonstrates  that 
neither IDDM nor significant levels of insulitis  develop in 
B  lymphocyte-deficient NOD.Ig/z  "uH mice that have fixed 
the necessary NOD-denved Idcl susceptibility loci to per- 
mit disease  development in the presence ofB lymphocytes. 
Verifying that all Idcl loci normally necessary for IDDM 
development are fixed in an NOD congenic stock is an es- 
sential prerequisite when determining whether the genetic 
elimination  of a  particular  immunological  component  af- 
fects  pathogenesis.  This  is  illustrated  by  two  consecutive 
studies from the same group, which analyzed the develop- 
ment of [3 cell autoimmumty in NOD mice congenic for a 
segment of chromosome 14 derived from the 129 strain that 
contained a functionally inactivated TCR-ot locus (12,  13). 
It was originally reported that in a heterozygous state,  the 
inactivated TCR-cx locus could block the development of 
cell autoimmunity in NOD mice (12).  However, as por- 
tions  of the  congenic  segment recombined to  NOD  type 
with  further backcrossing,  it was subsequently  found  that 
the originally reported resistance was not due to the inacti- 
vated TCtk-~x locus,  but rather to the  presence of linked 
129-derived  resistance  alleles  at  the  previously  identified 
Idd8 and/or Idcl12 loci on chromosome 14 (13). Our geno- 
typic analysis,  coupled with the normal rate of disease  de- 
velopment in the B lymphocyte-intact segregants, indicates 
that  complete  IDDM resistance in  the  NOD.Ig/*  "u" stock 
cannot be ascribed to the presence of 129 or B6 derived re- 
sistance alleles at any previously identified Idd loci. To date, 
when  any single  non-MHC  Idd resistance locus  has been 
congenically  fixed  to  homozygosity  on  the  NOD  back- 
ground, it has not resulted in complete IDDM and lnsulitls 
resistance in females as observed in our NOD.Igl.V 'u" stock. 
Thus,  it is highly unlikely that the  absence of IDDM and 
insulitis in our NOD.Ig/.t  ""tl stock is due to a previously un- 
identified  recessively  acting  129  derived  resistance  allele 
linked to the functionally inactivated Igt* gene.  This con- 
clusion is further supported by the fact that while numer- 
ous Idd susceptibility and resistance loci with major to very 
minor  effects  have  mapped  in  outcross  studies  of NOD 
mice with  a  number of different diabetes resistant  strains, 
none of these have mapped to chromosome 12 where Igl,* 
is located  (1,  14).  Hence,  these  past studies  coupled with 
our  current  findings  clearly  indicate  that  B  lymphocytes 
play a heretofore unrecognized role that is essential for the 
initial development and/or activation of [3 cell autoreactive 
T  cells in NOD mice. 
The mechanism(s) by which  B  lymphocytes contribute 
to the initial  development of diabetogenic T  lymphocytes 
in NOD mice remains to be elucidated.  It has been previ- 
ously proposed that in very young NOD  mice,  autoanti- 
bodies secreted by B lymphocytes bind to pancreatic [3 cells, 
and that this triggers an autoreactive T  cell cascade through 
an Ab-dependent  cell-mediated  cytotoxiclty (ADCC)  re- 
sponse (15). However, if such an ADCC mechanism is essen- 
tial to dlabetogenesis in NOD mice, it cannot be mediated 
by maternally transmitted autoantibodies,  since  equivalent 
degrees of disease  resistance were observed in NOD.IgI~""" 
segregants  denved from either B lymphocyte intact (Igl  x''""/+) 
or deficient  (Igt  x'''It) dams.  Future  studies will  examine the 
possibility  that  diabetogenic  T  lymphocytes  are  initially 
triggered by an ADCC response by determining if disease 
resistance is abrogated in  NOD.Ig/x  "uil mice injected  with 
Ig isolated from standard NOD donors with high islet  cell 
autoantibody ttters. Another, not mutually exclusive, possi- 
bility is that B lymphocytes contribute to the development 
of autoimmune IDDM in NOD mice through their role as 
APC. It has been reported that B lymphocytes may have a 
greater capacity than other APC to activate immunoregula- 
tory functions that may block the development of IDDM, 
such as rendering autoreactive T  cells anergic or skewing the 
pattern  of cytokines  they  produce  from a  Thl  to  a  Th2 
profile (3, 4). However, our finding that autolmmune IDDM 
is completely inhibited rather than enhanced in NOD.Igl.t''" 
mice indicates that the development and/or activation of 13 
cell-autoreactive T  cells is not normally blocked by such 
B  lymphocyte-controlled immunoregulatory mechanisms. 
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port that B  lymphocytes are not required for the induction 
of peripheral T  cell tolerance (5).  On the other hand,  our 
data  do  not  exclude  the  possibility that  the  diabetogenic 
function ofB lymphocytes m  NOD  mice is as APC with a 
unique ability to process and present certain 13 cell autoanti- 
gens to autoreactive T  cells. This possibility is currently be- 
ing  tested  by  determining if the  B  lymphocyte-deficient 
NOD.Ig/.t  "u" stock differs from standard NOD  mice in abil- 
ity to process and present certain candidate [3 cell autoanti- 
gens such  as glutamic acid decarboxylase and insulin to T 
cells (16-18). 
Most previous analyses of B  lymphocyte function in the 
NOD  mouse  have  focused  on  the  spontaneous  develop- 
ment  of autoantibodies against putative islet cell antigens. 
Autoantibody production in NOD  mice has been assumed 
to be  a  secondary consequence  of [3  cell destruction,  and 
hence,  B  lymphocytes  have  been  regarded  as  accessories 
rather than primary instigators of pathogenesis. Our results 
clearly delineate a  previously unidentified primary patho- 
genic  role  for  B  lymphocytes  in  IDDM  initiation in  the 
NOD  mouse. The mechanism(s) by which B  lymphocytes 
contribute  to  the  initiation  of  autolmmune  IDDM  in 
NOD  mice remain to be elucidated. However, knowledge 
of these mechanisms may provide new avenues for predict- 
ing  and/or  preventing  the  development  of autoimmune 
IDDM in humans. 
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